Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dr. Mantelli, former Chief Medical Officer at Dompé, spearheaded the successful clinical development program and FDA approval of Oxervate®, a blockbuster orphan therapy in corneal diseaseDr. Mantelli...
-
Apothecare calls for medical cannabis education to be integrated into clinical training in response to new guidance from Health Canada.
-
Integer Holdings Corporation Accused of Misrepresentations about its Sales Outlook in Securities Fraud Class Action – Investors Notified to Contact BFA Law
-
HAIFA, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq, TASE: PLUR), a biotechnology company leveraging its proprietary platform for cell-based...
-
New York, N.Y., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced...
-
BFA Law Hits Ardent Health, Inc. with Securities Class Action after Stock Plummets 33% -- Contact the Firm by March 9 if You Lost Money
-
FSR Invests in New Round of Research Awards to Drive Breakthroughs in Diagnosis and Treatment of Sarcoidosis
-
Austin, TX, USA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Thermoplastic Polyurethane TPU Market Size, Trends and Insights By Type...
-
Important Integer Holdings Corporation Securities Class Action Deadline Approaching for Investors seeking Recovery – Contact BFA Law by February 9
-
Integer Holdings Corporation Class Action Deadline February 9 – Investors Notified to Contact BFA Law to Protect Your Rights